GSK plc - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US37733W2044

SecurityGSK / GSK plc - Depositary Receipt (Common Stock)
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in GSK / GSK plc - Depositary Receipt (Common Stock)

On August 18, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of GSK plc - Depositary Receipt (Common Stock) (US:GSK) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 37,079 shares of GSK plc - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (GSK) in the form of stock options. The firm currently holds call options representing 76,100 of underlying shares valued at $3,127,710 USD and put options representing 36,200 of underlying shares valued at $1,487,820 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GSK / GSK plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-18 2025-06-30 13F GSK SPONSORED ADR 37733W204 0 -37,079 -100.00 0 -100.00
2025-05-15 2025-03-31 13F GSK SPONSORED ADR 37733W204 37,079 25,205 212.27 1,436 259.90 0.0017
2025-02-14 2024-12-31 13F GSK SPONSORED ADR 37733W204 11,874 11,874 400 0.0004
2024-08-14 2024-06-30 13F GSK SPONSORED ADR 37733W204 0 -12,510 -100.00 0 -100.00
2024-05-15 2024-03-31 13F GSK SPONSORED ADR 37733W204 12,510 5,686 83.32 536 112.70 0.0005
2024-02-14 2023-12-31 13F GSK SPONSORED ADR 37733W204 6,824 -18,423 -72.97 253 -72.46 0.0003
2023-11-15 2023-09-30 13F GSK SPONSORED ADR 37733W204 25,247 25,247 915 0.0009
2023-08-23 2023-06-30 13F GSK SPONSORED ADR 37733W204 0 -8,884 -100.00 0 0.0000
2023-05-15 2023-03-31 13F GSK SPONSORED ADR 37733W204 8,884 -13,699 -60.66 0 -100.00 0.0005
2023-02-14 2022-12-31 13F GSK SPONSORED ADR 37733W204 22,583 -38,111 -62.79 794 -55.44 0.0012
2022-11-14 2022-09-30 13F GSK SPONSORED ADR 37733W204 60,694 60,694 1,782 0.0029
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F GSK SPONSORED ADR Call 76,100 -32.17 3,128 -27.75 n/a n/a n/a
2025-08-18 2025-06-30 13F GSK SPONSORED ADR Call 112,200 20.65 4,329 20.16 n/a n/a n/a
2025-05-15 2025-03-31 13F GSK SPONSORED ADR Call 93,000 73.51 3,603 99.78 n/a n/a n/a
2025-02-14 2024-12-31 13F GSK SPONSORED ADR Call 53,600 -32.07 1,804 -43.87 n/a n/a n/a
2024-11-14 2024-09-30 13F GSK SPONSORED ADR Call 78,900 3,212 n/a n/a n/a
2024-08-14 2024-06-30 13F GSK SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F GSK SPONSORED ADR Call 95,500 -15.04 4,094 -1.70 n/a n/a n/a
2024-02-14 2023-12-31 13F GSK SPONSORED ADR Call 112,400 9.55 4,166 11.99 n/a n/a n/a
2023-11-15 2023-09-30 13F GSK SPONSORED ADR Call 102,600 -30.63 3,719 -29.00 n/a n/a n/a
2023-08-23 2023-06-30 13F GSK SPONSORED ADR Call 147,900 13.77 5,239 130,850.00 n/a n/a n/a
2023-05-15 2023-03-31 13F GSK SPONSORED ADR Call 130,000 -4.83 5 -99.92 n/a n/a n/a
2023-02-14 2022-12-31 13F GSK SPONSORED ADR Call 136,600 -3.39 4,800 15.61 n/a n/a n/a
2022-11-14 2022-09-30 13F GSK SPONSORED ADR Call 141,400 4,152 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F GSK SPONSORED ADR Put 36,200 -46.05 1,488 -42.54 n/a n/a n/a
2025-08-18 2025-06-30 13F GSK SPONSORED ADR Put 67,100 -41.04 2,589 -41.29 n/a n/a n/a
2025-05-15 2025-03-31 13F GSK SPONSORED ADR Put 113,800 185.93 4,409 229.20 n/a n/a n/a
2025-02-14 2024-12-31 13F GSK SPONSORED ADR Put 39,800 39.16 1,339 15.03 n/a n/a n/a
2024-11-14 2024-09-30 13F GSK SPONSORED ADR Put 28,600 1,164 n/a n/a n/a
2024-08-14 2024-06-30 13F GSK SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F GSK SPONSORED ADR Put 50,000 -27.75 2,144 -16.42 n/a n/a n/a
2024-02-14 2023-12-31 13F GSK SPONSORED ADR Put 69,200 33.85 2,565 36.82 n/a n/a n/a
2023-11-15 2023-09-30 13F GSK SPONSORED ADR Put 51,700 -30.32 1,874 -28.69 n/a n/a n/a
2023-08-23 2023-06-30 13F GSK SPONSORED ADR Put 74,200 45.21 2,628 262,700.00 n/a n/a n/a
2023-05-15 2023-03-31 13F GSK SPONSORED ADR Put 51,100 -44.64 2 -99.97 n/a n/a n/a
2023-02-14 2022-12-31 13F GSK SPONSORED ADR Put 92,300 -5.43 3,243 13.15 n/a n/a n/a
2022-11-14 2022-09-30 13F GSK SPONSORED ADR Put 97,600 2,866 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.